Page last updated: 2024-08-24

gemcitabine and lcl161

gemcitabine has been researched along with lcl161 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Berg, M; Cinatl, J; Michaelis, M; Rothweiler, F; Stege, H; Vallo, S; Winkelmann, R	1

Other Studies

1 other study(ies) available for gemcitabine and lcl161

Article	Year
Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy. Oncology reports, 2020, Volume: 43, Issue:4 Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cisplatin; Deoxycytidine; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Signal Transduction; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Urinary Bladder Neoplasms; Urothelium; X-Linked Inhibitor of Apoptosis Protein	2020

Article

Year

Tumor necrosis factor‑related apoptosis‑inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first‑line chemotherapy.

Oncology reports, 2020, Volume: 43, Issue:4

Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Cisplatin; Deoxycytidine; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Signal Transduction; Thiazoles; TNF-Related Apoptosis-Inducing Ligand; Urinary Bladder Neoplasms; Urothelium; X-Linked Inhibitor of Apoptosis Protein

2020